Archives: Healthcare

Subscribe to Healthcare RSS Feed

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS Outgoing FDA Commissioner Scott Gottlieb and the No. 2 official at HHS will be on Capitol Hill this week testifying on the Trump administration’s proposed budget for fiscal … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting pharma introduced; medical device tax repeal legislation introduced – but only in the Senate; outpatient physicians plan to lobby on … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices; bill introduction suspending medical device tax delayed; Grassley renews nursing home abuse inquiry; more committees hold more drug pricing hearings; and more.… Continue Reading

Finger-pointing but few fireworks at Senate hearing on drug prices

Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy concessions to address drug prices. They avoided gaffes and left the industry in no worse a political position than before the hearing. Democrats predictably were unsatisfied, … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe insulin prices; medical device tax suspension bills to be introduced; Gottlieb to testify before House panel; and more.… Continue Reading

Senate Democrats recently introduced the Stop Price Gouging Act

Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs. The bill generally requires a company to justify to the Department of Health and Human Services (DHHS) any spike in prescription drug prices, but it is … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: shutdown risk increases as talks stall; Gottlieb’s Hill testimony postponed; more bills targeting drug prices introduced; hearing focuses on bolstering ACA; and more.… Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address; Democrats criticize HHS’ drug rebate proposal; dueling hearings highlight the ACA’s pre-existing conditions; House Democrat reveals her cancer is … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug prices; House GOP questions CMS on Medicaid managed care; and more.… Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. We’re posting on Tuesday this week because of the Martin Luther King, Jr. federal holiday. Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more.… Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: how the partial government shutdown is affecting operations at the FDA; House Democrats take steps to defend the ACA; the House votes this week to renew emergency health response programs; new senators are added … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week include a lame duck update on year-end health bills and tax provisions; lawmakers reacting to a federal judge ruling the Affordable Care Act is unconstitutional; Sen. Hatch seeks to update Hatch-Waxman; health providers targeted … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Lawmakers renew efforts to avoid a partial government shutdown, which would affect FDA; key senators introduce legislation on Medicaid prescription drug rebates; the House votes this week on allowing states to coordinate care for … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key Democrat says … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Democrats’ takeover of the House will yield big changes for healthcare policy in 2019; several GOP lawmakers active in healthcare policy are defeated; pharma pushes for Part D changes in the lame duck; and … Continue Reading

Five Things to Know: What the Election Results Mean for Healthcare Policy

Democrats’ slender majority in the House next year will have an outsized impact on healthcare policy and healthcare stakeholders in 2019 and beyond. From potential bipartisan deals on prescription drug prices to Democrats’ “shock and awe” oversight agenda, here are five things to know about what the 2018 midterm election results mean for healthcare policy … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: The Senate will give the final OK to opioids legislation, HHS gets full-year funding for the first time in forever, new bipartisan legislation would allow FDA to update labels on older generic drugs, and … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Included this week is an update on congressional efforts to finish opioids response legislation; efforts by pharmaceutical manufacturers to change discounts they are required to provide Medicare beneficiaries in the Part D donut hole; the status of … Continue Reading

Senate OKs Opioids Response Bill as Lawmakers Scramble to Pass Final Measure

The Senate this week overwhelmingly approved legislation to address the opioid crisis, and now Congress is racing to cobble together a final measure that could pass before the midterm elections in November. The Senate-passed legislation is sweeping in scope: It is composed of more than 70 individual bills approved by five committees. Packaged together, this legislation … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” posted on Mondays when Congress is in session. Featured in this week’s Update, the Senate votes today on opioids legislation (the House is not in session this week); Congress reaches an agreement on fiscal 2019 healthcare funding; the pharma industry last week suffers both a setback and … Continue Reading

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on a pending Senate vote on opioid legislation as Congress races to enact a response to the crisis before the November election; the Senate votes to expand Sunshine Act disclosure requirements; and a key House Republican backs requiring drug manufacturers to include prices in their ads; … Continue Reading

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on Congress reconvening after a summer break and facing near-term deadlines on government funding, including for healthcare agencies and programs; whether Congress will approve opioids legislation before the November elections; an unlikely alliance of Senate Democrats and the Trump administration on requiring drug manufacturers to include … Continue Reading
LexBlog